Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta ‐analysis

Conclusions: Early experience suggests that SGB is associated with an acute reduction in the VA burden and offers potential promise for a broader use in high‐risk populations. Randomized controlled studies are needed to confirm safety and efficacy of this therapy.This article is protected by copyright. All rights reserved

Source: Journal of Cardiovascular Electrophysiology - August 18, 2017 Category: Cardiology Authors: Marat Fudim, Richard Boortz ‐Marx, Arun Ganesh, Nathan H. Waldron, Muhammad Y. Qadri, Chetan B. Patel, Carmello A. Milano, Albert Y Sun, Joseph P. Matthew, Jonathan P. Piccini Tags: ORIGINAL ARTICLE Source Type: research